tiprankstipranks
Trending News
More News >
Carl Zeiss Meditec (DE:AFX)
:AFX
Germany Market

Carl Zeiss Meditec (AFX) Ratios

Compare
88 Followers

Carl Zeiss Meditec Ratios

DE:AFX's free cash flow for Q1 2025 was €0.51. For the 2025 fiscal year, DE:AFX's free cash flow was decreased by € and operating cash flow was €0.06. See a summary of the company’s cash flow.
Ratios
TTM
Sep 24Sep 23Sep 22Sep 21
Liquidity Ratios
Current Ratio
3.32 3.40 3.32 3.58 4.34
Quick Ratio
2.61 2.48 2.61 2.94 3.38
Cash Ratio
0.01 0.02 0.01 0.02 0.02
Solvency Ratio
0.46 0.42 0.46 0.41 0.32
Operating Cash Flow Ratio
0.35 0.45 0.35 0.81 0.60
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 9.15
Net Current Asset Value
€ 999.13M€ 1.05B€ 999.13M€ 885.43M€ 730.02M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.05 0.05 0.05 0.03
Debt-to-Equity Ratio
0.06 0.07 0.06 0.07 0.05
Debt-to-Capital Ratio
0.06 0.07 0.06 0.07 0.05
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.04 0.06
Financial Leverage Ratio
1.40 1.40 1.40 1.44 1.41
Debt Service Coverage Ratio
39.07 25.06 39.07 32.85 4.45
Interest Coverage Ratio
43.06 21.45 43.06 37.20 7.41
Debt to Market Cap
0.00 0.00 0.00 <0.01 0.01
Interest Debt Per Share
1.54 1.91 1.54 1.46 1.08
Net Debt to EBITDA
0.25 0.29 0.25 0.28 0.24
Profitability Margins
Gross Profit Margin
59.26%57.71%59.26%58.73%55.83%
EBIT Margin
21.71%20.48%21.71%21.16%15.47%
EBITDA Margin
25.35%24.06%25.35%24.85%19.95%
Operating Profit Margin
21.71%15.66%21.71%21.16%15.47%
Pretax Profit Margin
21.20%19.75%21.20%20.59%13.38%
Net Profit Margin
15.45%13.90%15.45%14.35%9.16%
Continuous Operations Profit Margin
15.55%13.98%15.55%14.42%9.24%
Net Income Per EBT
72.84%70.39%72.84%69.69%68.48%
EBT Per EBIT
97.68%126.11%97.68%97.31%86.50%
Return on Assets (ROA)
10.41%9.57%10.41%9.86%6.08%
Return on Equity (ROE)
14.59%13.45%14.59%14.24%8.55%
Return on Capital Employed (ROCE)
18.09%13.24%18.09%17.89%12.04%
Return on Invested Capital (ROIC)
13.14%9.29%13.14%12.41%8.15%
Return on Tangible Assets
13.65%12.32%13.65%12.35%7.94%
Earnings Yield
3.06%3.92%3.06%1.59%1.27%
Efficiency Ratios
Receivables Turnover
1.39 234.17 1.39 1.27 -1.34K
Payables Turnover
4.10 3.68 4.10 4.67 6.43
Inventory Turnover
2.03 1.70 2.03 2.37 2.06
Fixed Asset Turnover
8.06 6.62 8.06 8.25 9.87
Asset Turnover
0.67 0.69 0.67 0.69 0.66
Working Capital Turnover Ratio
1.58 1.61 1.58 1.53 1.36
Cash Conversion Cycle
353.24 117.41 353.24 362.64 120.18
Days of Sales Outstanding
262.11 1.56 262.11 286.95 -0.27
Days of Inventory Outstanding
180.21 214.91 180.21 153.81 177.17
Days of Payables Outstanding
89.07 99.06 89.07 78.13 56.72
Operating Cycle
442.31 216.47 442.31 440.76 176.90
Cash Flow Ratios
Operating Cash Flow Per Share
2.10 2.80 2.10 4.05 2.00
Free Cash Flow Per Share
1.19 1.53 1.19 3.32 1.49
CapEx Per Share
0.92 1.27 0.92 0.74 0.50
Free Cash Flow to Operating Cash Flow
0.56 0.55 0.56 0.82 0.75
Dividend Paid and CapEx Coverage Ratio
1.16 1.18 1.16 3.27 1.73
Capital Expenditure Coverage Ratio
2.30 2.20 2.30 5.49 3.97
Operating Cash Flow Coverage Ratio
1.47 1.61 1.47 2.99 2.60
Operating Cash Flow to Sales Ratio
0.10 0.12 0.10 0.22 0.13
Free Cash Flow Yield
1.11%1.85%1.11%2.00%1.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
32.70 25.51 32.70 62.86 78.93
Price-to-Sales (P/S) Ratio
5.05 3.55 5.05 9.02 7.23
Price-to-Book (P/B) Ratio
4.77 3.43 4.77 8.95 6.75
Price-to-Free Cash Flow (P/FCF) Ratio
90.47 54.07 90.47 50.08 72.33
Price-to-Operating Cash Flow Ratio
51.07 29.53 51.07 40.95 54.11
Price-to-Earnings Growth (PEG) Ratio
1.33 -20.98 1.33 0.68 -3.36
Price-to-Fair Value
4.77 3.43 4.77 8.95 6.75
Enterprise Value Multiple
20.17 15.02 20.17 36.57 36.50
Enterprise Value
9.73B 7.55B 9.73B 14.97B 9.72B
EV to EBITDA
20.17 15.02 20.17 36.57 36.50
EV to Sales
5.11 3.61 5.11 9.09 7.28
EV to Free Cash Flow
91.60 55.13 91.60 50.46 72.81
EV to Operating Cash Flow
51.70 30.11 51.70 41.27 54.46
Tangible Book Value Per Share
15.21 16.74 15.21 13.36 10.95
Shareholders’ Equity Per Share
22.53 24.14 22.53 18.55 16.01
Tax and Other Ratios
Effective Tax Rate
0.27 0.29 0.27 0.30 0.31
Revenue Per Share
21.27 23.36 21.27 18.41 14.93
Net Income Per Share
3.29 3.25 3.29 2.64 1.37
Tax Burden
0.73 0.70 0.73 0.70 0.68
Interest Burden
0.98 0.96 0.98 0.97 0.87
Research & Development to Revenue
0.15 0.17 0.15 0.14 0.16
SG&A to Revenue
0.04 0.04 0.04 0.04 0.04
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.64 0.86 0.64 1.53 1.45
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis